MedReleaf (TSX:LEAF) issued a statement in response to the Canadian federal government’s proposals on the regulation of cannabis.

As quoted in the press release:

As a licensed producer of cannabis, our goal is to ensure consumers have access to all the facts and details necessary to make informed decisions when purchasing cannabis products. On this point, we believe Health Canada’s packaging and branding recommendations miss the mark. Defaulting to a tobacco-like regime fails to recognize fundamental differences between products, or to account for current and future variations in consumption methods, such as oils or capsules.

We believe the common-sense and true risk-based approach is to regulate cannabis in a way similar to alcohol and provide consumers the ability to distinguish between brands (and all they represent) including product types, qualities, varieties, effects, sources of origin and awards garnered. As a dedicated corporate partner in the delivery of legal and regulated cannabis products, we firmly believe that adult-focused branded packaging will also better differentiate legal products from black market offerings thereby serving a fundamental public policy objective.

While we applaud the government in making these recommendations accessible for public review, we ask Health Canada to work with us to further refine their recommendations. Finding a compromise position on potentially unsafe suggestions for branding, packaging, and labeling requirements is in the best interest of all Canadians.

Click here to read the full press release.


American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less